Artikler iht.:

Tidlig diagnose af Tarmkræft

 

Increased serological, cancer-associated protein biomarker levels at diagnosis of large bowel adenoma:
Risk of subsequent primary malignancy?

Piper TB, Jørgensen LN, Olsen J, Nielsen KT, Davis G, Johansen JS,Jarle Christensen I, Nielsen HJ

Acta Oncol. 2019 58(sup1):S42-S48. doi: 10.1080/0284186X.2018.1540885.
Epub 2018 Dec 7.

 

Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer

Rasmussen L, Christensen IJ, Herzog M, et al.

Oncotarget (2018 Feb)
Issue 12 p. 10247-10258 issn:1949-2553)

 

Increased serological cancer-associated biomarkers and risk of development of primary malignancy after large bowel endoscopy.

Nielsen, HJ

Scand J Gastroenterol. 2016 Oct;51(10):1272. doi: 10.1080/00365521.2016.1195442. Epub 2016 Jun 16.

 

Pre-analytical variables of circulating cell-free nucleosomes containing 5-methylcytosine DNA or histone modification H3K9Me3.

Rasmussen L,  Herzog M.,  Rømer E.,  Micallef J,  Bulut O.,  Wilhelmsen M.,  Christensen I., Nielsen HJ.

Scand J Clin Lab Invest. 2016 Oct;76(6):448-53. doi: 10.1080/00365513.2016.1190862. Epub 2016 Jun 13.

 

Plasma levels of OLFM4 in normals and patients with gastrointestinal cancer.

Clemmensen SN, Glenthøj AJ, Heebøll S, Nielsen HJ, Koch C, Borregaard N.

J Cell Mol Med. 2015 Dec;19(12):2865-73. doi: 10.1111/jcmm.12679. Epub 2015 Sep 28.

 

Blood-based Biomarkers at Large Bowel Endoscopy and Prediction of Future Malignancies.

Kring TS, Piper TB, Jørgensen LN, Olsen J, Rahr HB, Nielsen KT, Laurberg S, Davis G, Dowell B, Johansen JS, Christensen IJ, Brünner N, Nielsen HJ.

Biomark Cancer. 2015 Oct 22;7:57-61. doi: 10.4137/BIC.S31330. eCollection 2015.

 

Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study.

Ørntoft MB, Nielsen HJ, Ørntoft TF, Andersen CL; Danish Study Group on Early Detection of Colorectal Cancer.

BMC Cancer. 2015 Oct 29;15:819. doi: 10.1186/s12885-015-1832-6.

 

Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal Cancer: A Prospective Validation Study Including Symptomatic and Non-symptomatic Individuals.

Christensen IJ, Brünner N, Dowell B, Davis G, Nielsen HJ, Newstead G, King D.

Anticancer Res. 2015 Sep;35(9):4935-41.

 

Serum YKL-40 in risk assessment for colorectal cancer: a prospective study of 4,496 subjects at risk of colorectal cancer.

Johansen JS, Christensen IJ, Jørgensen LN, Olsen J, Rahr HB, Nielsen KT, Laurberg S, Brünner N, Nielsen HJ.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):621-6. doi: 10.1158/1055-9965.EPI-13-1281. Epub 2015 Jan 18.

 

Evaluation of complement proteins as screening markers for colorectal cancer.

Storm L, Christensen IJ, Jensenius JC, Nielsen HJ, Thiel S; Danish Study Group on Early Detection of Colorectal Cancer.

Cancer Immunol Immunother. 2015 Jan;64(1):41-50. doi: 10.1007/s00262-014-1615-y. Epub 2014 Sep 27.

 

Basis data for “Triage i screening for tarmkræft”:

Serological biomarkers in triage of FIT-positive subjects?

Nielsen HJ, Christensen IJ, Andersen B, Rasmussen M, Friis-Hansen LJ, Bygott T, MiCallef J; Danish–Belgian Research Group on Early Detection of Colorectal Cancer.

Scand J Gastroenterol. 2017 Jun – Jul;52(6-7):742-744. doi: 10.1080/00365521.2017.1299212. Epub 2017 Mar 8.